Search - tctmd.com

Displaying 121 - 140 of 182

Sort: Relevancy | Date

News Daily News

La Fibrilación Auricular Post-IAM Acarrea Malos Resultados

Yael L. Maxwell

May 01, 2015

News Daily News

ISAR-TRIPLE Published: No Net Gain for 6 Weeks vs 6 Months of Triple Therapy

April 29, 2015

News Daily News

很小一部分低风险房颤患者仍然被给予抗凝血剂

Salynn Boyles

April 28, 2015

News Daily News

Una Gran Minoría de Pacientes con Fibrilación Auricular de Bajo Riesgo Siguen Recibiendo Anticoagulantes

Salynn Boyles

April 28, 2015

News Daily News

Substantial Minority of Low-Risk A-fib Patients Still Given Anticoagulants

Salynn Boyles

April 28, 2015

News Daily News

Pharmacists May Help Ameliorate Substantial Variation in Dabigatran Adherence

Todd Neale

April 17, 2015

News Daily News

Concomitant NSAID, Antithrombotic Therapy Increases Bleeding, CV Events After MI

Yael L. Maxwell

February 25, 2015

News Daily News

HF Worsens Outcomes Following ACS, With No Benefit From Apixaban

Todd Neale

January 28, 2015

Presentation

Of 7,372 patients from the ORBIT-AF registry treated with oral anticoagulants, 2,200 had at least 1 interruption and bridging was used in 24%_

Presenter: Benjamin A. Steinberg

December 22, 2014

News Daily News

Study Suggests Routine Bridging Harmful for A-fib Patients Interrupting Anticoagulation

December 22, 2014

News Daily News

Registro del CORONOR: Warfarin a Largo Plazo + Agente Antiplaquetario Aumenta las Hemorragias en Pacientes con EAC Estable

L.A. McKeown

October 03, 2014

News Daily News

CORONOR Registry: Long-term Warfarin Plus Antiplatelet Increases Bleeding in Stable CAD Patients

L.A. McKeown

October 03, 2014

News Daily News

ROCKET AF Substudy: Rivaroxaban Safe, Effective in East Asian Patients

L.A. McKeown

April 29, 2014

News Daily News

ROCKET AF Analysis Isolates Predictors of Intracranial Hemorrhage in A-fib Population

L.A. McKeown

April 22, 2014

News Daily News

Apixaban es Rentable comparado con Warfarina o Aspirina

Caitlin E. Cox

February 26, 2014

News Daily News

Apixaban Cost-Effective Compared with Warfarin or Aspirin

Caitlin E. Cox

February 26, 2014

News Daily News

Similar Efficacy, Less Bleeding With Dabigatran vs. Warfarin in VTE Patients

Yael L. Maxwell

January 01, 2014

News Daily News

Meta-analyses: Novel Anticoagulants Halve Intracranial Hemorrhage vs. Warfarin

January 01, 2014

News Daily News

Meta Análisis: Comparados con la Warfarina los Nuevos Anticoagulantes Reducen a la Mitad las Hemorragias Intracraneales

January 01, 2014

News Daily News

Rivaroxaban Antidote Appears Safe, Effective in Early Study

December 30, 2013

Advertisement

La Fibrilación Auricular Post-IAM Acarrea Malos Resultados

ISAR-TRIPLE Published: No Net Gain for 6 Weeks vs 6 Months of Triple Therapy

很小一部分低风险房颤患者仍然被给予抗凝血剂

Una Gran Minoría de Pacientes con Fibrilación Auricular de Bajo Riesgo Siguen Recibiendo Anticoagulantes

Substantial Minority of Low-Risk A-fib Patients Still Given Anticoagulants

Pharmacists May Help Ameliorate Substantial Variation in Dabigatran Adherence

Concomitant NSAID, Antithrombotic Therapy Increases Bleeding, CV Events After MI

HF Worsens Outcomes Following ACS, With No Benefit From Apixaban

Of 7,372 patients from the ORBIT-AF registry treated with oral anticoagulants, 2,200 had at least 1 interruption and bridging was used in 24%_

Study Suggests Routine Bridging Harmful for A-fib Patients Interrupting Anticoagulation

Registro del CORONOR: Warfarin a Largo Plazo + Agente Antiplaquetario Aumenta las Hemorragias en Pacientes con EAC Estable

CORONOR Registry: Long-term Warfarin Plus Antiplatelet Increases Bleeding in Stable CAD Patients

ROCKET AF Substudy: Rivaroxaban Safe, Effective in East Asian Patients

ROCKET AF Analysis Isolates Predictors of Intracranial Hemorrhage in A-fib Population

Apixaban es Rentable comparado con Warfarina o Aspirina

Apixaban Cost-Effective Compared with Warfarin or Aspirin

Similar Efficacy, Less Bleeding With Dabigatran vs. Warfarin in VTE Patients

Meta-analyses: Novel Anticoagulants Halve Intracranial Hemorrhage vs. Warfarin

Meta Análisis: Comparados con la Warfarina los Nuevos Anticoagulantes Reducen a la Mitad las Hemorragias Intracraneales

Rivaroxaban Antidote Appears Safe, Effective in Early Study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content